These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 3086977

  • 1. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans.
    Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M.
    Science; 1986 Jun 20; 232(4757):1545-7. PubMed ID: 3086977
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
    Hong TP, Andersen NA, Nielsen K, Karlsen AE, Fantuzzi G, Eizirik DL, Dinarello CA, Mandrup-Poulsen T.
    Eur Cytokine Netw; 2000 Jun 20; 11(2):193-205. PubMed ID: 10903798
    [Abstract] [Full Text] [Related]

  • 3. Species differences in human and rat islet sensitivity to human cytokines. Monoclonal anti-interleukin-1 (IL-1) influences on direct and indirect IL-1-mediated islet effects.
    Kawahara DJ, Kenney JS.
    Cytokine; 1991 Mar 20; 3(2):117-24. PubMed ID: 1888882
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-1 inhibits glucose-modulated insulin and glucagon secretion in rat islet monolayer cultures.
    Rabinovitch A, Pukel C, Baquerizo H.
    Endocrinology; 1988 Jun 20; 122(6):2393-8. PubMed ID: 2453340
    [Abstract] [Full Text] [Related]

  • 5. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.
    Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J.
    J Immunol; 1987 Dec 15; 139(12):4077-82. PubMed ID: 3320203
    [Abstract] [Full Text] [Related]

  • 6. Effects of cytokines on rat pancreatic islet cell monolayer cultures: distinction between functional and cytotoxic effects on islet beta-cells.
    Rabinovitch A, Baquerizo H, Pukel C, Sumoski W.
    Reg Immunol; 1989 Dec 15; 2(2):77-82. PubMed ID: 2518361
    [Abstract] [Full Text] [Related]

  • 7. Recombinant human transforming growth factor beta does not inhibit the effects of interleukin-1 beta on pancreatic islet cells.
    Hao W, Palmer JP.
    J Interferon Cytokine Res; 1995 Dec 15; 15(12):1075-81. PubMed ID: 8746789
    [Abstract] [Full Text] [Related]

  • 8. Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans.
    Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH.
    Diabetologia; 1986 Jan 15; 29(1):63-7. PubMed ID: 3514344
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.
    Sandler S, Bendtzen K, Eizirik DL, Welsh M.
    Endocrinology; 1990 Feb 15; 126(2):1288-94. PubMed ID: 2404746
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture.
    Rabinovitch A, Sumoski W, Rajotte RV, Warnock GL.
    J Clin Endocrinol Metab; 1990 Jul 15; 71(1):152-6. PubMed ID: 2115042
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans.
    Corbett JA, Sweetland MA, Wang JL, Lancaster JR, McDaniel ML.
    Proc Natl Acad Sci U S A; 1993 Mar 01; 90(5):1731-5. PubMed ID: 8383325
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-1 alpha exerts glucose-dependent stimulatory and inhibitory effects on islet cell phosphoinositide hydrolysis and insulin secretion.
    Zawalich WS, Zawalich KC, Rasmussen H.
    Endocrinology; 1989 May 01; 124(5):2350-7. PubMed ID: 2539976
    [Abstract] [Full Text] [Related]

  • 15. Strain-dependent differences in sensitivity of rat beta-cells to interleukin 1 beta in vitro and in vivo: association with islet nitric oxide synthesis.
    Reimers JI, Andersen HU, Mauricio D, Pociot F, Karlsen AE, Petersen JS, Mandrup-Poulsen T, Nerup J.
    Diabetes; 1996 Jun 01; 45(6):771-8. PubMed ID: 8635652
    [Abstract] [Full Text] [Related]

  • 16. IL-1 produced and released endogenously within human islets inhibits beta cell function.
    Arnush M, Heitmeier MR, Scarim AL, Marino MH, Manning PT, Corbett JA.
    J Clin Invest; 1998 Aug 01; 102(3):516-26. PubMed ID: 9691088
    [Abstract] [Full Text] [Related]

  • 17. A naturally occurring 6-9-kilodalton interleukin-1 (IL-1) inhibitor prevents IL-1-mediated islet cytotoxicity but not IL-1-mediated suppression of insulin secretion.
    Kawahara DJ, Everts M, Buckingham B, Sandborg C, Berman M.
    J Immunother (1991); 1991 Jun 01; 10(3):182-8. PubMed ID: 1868042
    [Abstract] [Full Text] [Related]

  • 18. Islet cytotoxicity of interleukin 1. Influence of culture conditions and islet donor characteristics.
    Mandrup-Poulsen T, Spinas GA, Prowse SJ, Hansen BS, Jørgensen DW, Bendtzen K, Nielsen JH, Nerup J.
    Diabetes; 1987 May 01; 36(5):641-7. PubMed ID: 3552796
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans.
    Comens PG, Wolf BA, Unanue ER, Lacy PE, McDaniel ML.
    Diabetes; 1987 Aug 01; 36(8):963-70. PubMed ID: 3297891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.